Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
May 23, 2019

Amgen to acquire Danish firm Nuevolution for £132m

US-based drugmaker Amgen has agreed to acquire Denmark-based small molecule drug discovery platform biotech firm Nuevolution for around $167m (£132m).

Image: Amgen headquarters in Thousand Oaks, California. Photo: courtesy of Coolcaesar.